| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/31/2002 | WO2002008734A2 Methods using light emission for determining the effectiveness of plant treatment agents in controlling plant disease organisms |
| 01/31/2002 | WO2002008733A1 Method for determining the activity of uncoupling proteins (ucps) by monitoring nad(p)h consumption |
| 01/31/2002 | WO2002008728A1 Modified erythrocyte sedimentation rate |
| 01/31/2002 | WO2002008727A1 Reagent delivery device and method of use |
| 01/31/2002 | WO2002008723A2 Method for the selective determination of blocking auto-antibodies to the tsh receptor |
| 01/31/2002 | WO2002008722A2 Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule |
| 01/31/2002 | WO2002008716A2 Method for screening peptides for use in immunotherapy |
| 01/31/2002 | WO2002008469A2 Methods, systems, and articles of manufacture for evaluating biological data |
| 01/31/2002 | WO2002008466A1 A systematic approach to mechanism-of-response analyses |
| 01/31/2002 | WO2002008458A1 Use of an imaging photoelectric flat sensor for evaluating biochips and imaging method therefor |
| 01/31/2002 | WO2002008452A1 Method of diagnosing breast cancer using nipple fluid |
| 01/31/2002 | WO2002008451A2 Assay for screening compounds for inducing drug metabolizing enzymes |
| 01/31/2002 | WO2002008450A2 Method for measuring jnk/sapk activity by phosphorylation of transcription factors |
| 01/31/2002 | WO2002008449A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 01/31/2002 | WO2002008419A1 Molecular markers |
| 01/31/2002 | WO2002008407A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008390A2 Bovine wasting syndrome vaccine |
| 01/31/2002 | WO2002008386A2 Materials and methods for the enhancement of effective root nodulation in legumes |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008262A2 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008261A2 Bstp-trans protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002008241A2 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/31/2002 | WO2002007935A1 Razor cartridge with painted and drawn retaining clip |
| 01/31/2002 | WO2002007821A1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity |
| 01/31/2002 | WO2002007779A1 Long wavelength long lifetime luminophores |
| 01/31/2002 | WO2002007765A2 REGULATORS OF PPARδ(β) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE |
| 01/31/2002 | WO2002007755A1 Lrp-mediated modulation of neuronal calcium influx via nmda receptors, and uses thereof |
| 01/31/2002 | WO2002007751A1 Identification and isolation of novel polypeptides having pdz domains and methods of using same |
| 01/31/2002 | WO2002007747A1 Methods of modulating fibrosis |
| 01/31/2002 | WO2002007722A2 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 01/31/2002 | WO2002007693A1 Improved diagnostic method for detecting dysplastic epithelial tissue |
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | WO2002007645A2 Pregnancy and sex identification test based on saliva or other bodily fluids |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001078889A3 A method of fabricating coded particles |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001073109A9 Continuous process for manufacture of disposable electro-chemical sensor |
| 01/31/2002 | WO2001068120A3 Uses of bombesin receptor 3 |
| 01/31/2002 | WO2001065255A3 Biosynthetic carbohydrate-deficient transferrin references |
| 01/31/2002 | WO2001065230A3 Personal drug testing kit |
| 01/31/2002 | WO2001063284A9 Internal standards and controls for multiplexed assay |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001059455A3 Immobilization of bioactive species |
| 01/31/2002 | WO2001051654A3 Methods and kits for identifying elite event gat-zm1 in biological samples |
| 01/31/2002 | WO2001050127A3 Screening using biological target molecules with metal-ion binding sites |
| 01/31/2002 | WO2001049883A3 Amplification based polymorphism detection |
| 01/31/2002 | WO2001048485A3 Selecting library members capable of binding to epitopes |
| 01/31/2002 | WO2001044811A3 Plasminogen activator assay involving an elastase inhibitor |
| 01/31/2002 | WO2001042792A3 Diagnosis of cervical cancer using marker proteins |
| 01/31/2002 | WO2001040784A3 Sensor accommodated in a housing |
| 01/31/2002 | WO2001040473A3 Pseudomonas aeruginosa antigens |
| 01/31/2002 | WO2001038845A3 Apparatus and methods for identifying ligands |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001029268A3 Method for identifying interacting gene products |
| 01/31/2002 | WO2001026536A3 Methods of diagnosing and treating hepatic cell proliferative disorders |
| 01/31/2002 | WO2001025794B1 Protein fingerprinting by multisite labelling |
| 01/31/2002 | WO2001012859A3 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000072869A9 Methods for producing 5'-nucleic acid-protein conjugates |
| 01/31/2002 | WO2000068434A3 Multiple tag analysis |
| 01/31/2002 | WO2000060124A3 Fixed address analysis of sequence tags |
| 01/31/2002 | WO2000060114A3 Polynucleotide sequencing using a helicase |
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | WO2000052473A3 Radiolabeling kit and binding assay |
| 01/31/2002 | WO2000049173A3 Method and sample support system for separating and processing substances in situ |
| 01/31/2002 | US20020013954 Whole-body optical imaging of gene expression and uses thereof |
| 01/31/2002 | US20020013662 Pharmacokinetic-based drug design tool and method |
| 01/31/2002 | US20020013536 Method and apparatus for respiratory gas analysis employing measurement of expired gas mass |
| 01/31/2002 | US20020013522 Medical apparatus for use by a patient for medical self treatment of diabetes |
| 01/31/2002 | US20020013455 Isolation and identification of novel polymerases |
| 01/31/2002 | US20020013430 Controlled free radical emulsion and water-based polymerizations and seeded methodologies |
| 01/31/2002 | US20020013374 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors |
| 01/31/2002 | US20020013372 Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors |
| 01/31/2002 | US20020013370 Methods for identifying and treating resistant tumors |
| 01/31/2002 | US20020013259 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 01/31/2002 | US20020013003 Site-specific, covalent bioconjugation of proteins |
| 01/31/2002 | US20020013002 Pregnancy test based on saliva or other bodily fluids |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/31/2002 | US20020012989 Genetically engineered nucleotide sequences coding preferential proteins for use in treatment of viral disease |
| 01/31/2002 | US20020012966 18 Human secreted proteins |
| 01/31/2002 | US20020012965 Nucleotide sequences coding prfeerential polypeptides for use in the diagnosis and treatment of brain disorders and injury |
| 01/31/2002 | US20020012963 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies |
| 01/31/2002 | US20020012960 Method of finding protoporphyrinogen oxidase inhibitors |
| 01/31/2002 | US20020012958 Increasing the fvii sensitivity of a thromboplastin reagent |
| 01/31/2002 | US20020012956 Composition for the detection of heart muscle damage |
| 01/31/2002 | US20020012955 Basophil degranulation test |